Research is being conducted on the metabolic processes involved in cancer, particularly in non-small cell lung cancer and its ability to colonize the brain. The studies appear to be exploring various axes and pathways, including the IGF2BP3-FASN axis, and their roles in metabolic reprogramming and tumor development. The investigations also seem to be touching on related topics, such as immunosuppression, ferroptosis regulation, and epigenetic modifications, in different types of cancer.